AUTL AUTOLUS THERAPEUTICS PLC Capital Structure Changes 8-K Filing 2023 - Regulation FD Disclosure Autolus Therapeutics plc has voluntarily chosen to file periodic and current reports on U.S. domestic issuer forms, while maintaining its status as a foreign private issuer.Get access to all SEC 8-K filings of the AUTOLUS THERAPEUTICS PLC